Stay updated with breaking news from Pharmaceutical Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gavocabtagene autoleucel is under clinical development by TCR2 Therapeutics and currently in Phase II for Ovarian Cancer.
Amisulpride is under clinical development by Sumitomo Pharma America and currently in Phase III for Bipolar Disorder (Manic Depression).
Linavonkibart is a monoclonal antibody commercialized by Scholar Rock Holding, with a leading Phase I program in Non-Small Cell Lung Cancer.
DSP-0038 is under clinical development by Sumitomo Pharma America and currently in Phase I for Alzheimer's Disease.
NMRA-511 is under clinical development by Neumora Therapeutics and currently in Phase I for Alzheimer's Disease.